Bibliometric Study of Sodium Glucose Cotransporter 2 Inhibitors in Cardiovascular Research

Abstract

Most studies focused on clinical trial outcomes, such as cardiovascular death and heart failure (HF) hospitalization. The mechanisms of SGLT2 inhibitors, especially those related to cardiac metabolism, may soon become hotspots and should be closely monitored.